Hina Mir is an Assistant Professor of Microbiology, Biochemistry, and Immunology at the Morehouse School of Medicine. She received her Bachelor’s degree in Biochemistry at the C. U. Shah Science College, Gujarat University, India, and earned her Master's of Science and Ph.D. in Biochemistry from the Maharaja Sayajirao University of Baroda, India. Her research goal is to define the cellular and molecular mechanism of colon cancer progression and metastasis, and develop therapeutics to improve treatment outcomes and patient survival. She is interested in studying the CCR6-CCL20 induced signaling mechanisms that contribute to colon cancer progression and in evaluating the potential of CCR6-directed therapy on the efficacy of conventional chemotherapeutics.
Dr. Eric L. Flenaugh is an Associate Professor and vice Chair. He completed his pulmonary training at UTHSC- Houston & MD Anderson Cancer Center. He was recruited by the Morehouse School of Medicine and joined the Grady Health System to establish a dedicated advanced diagnostic and interventional Pulmonary Service for the Georgia Cancer Center of Excellence. As part of the GHS Faculty, he has performed grant-funded and award-winning research, published in peer-reviewed journals, authored book chapters, served on multiple hospital committees, established clinical service lines with the development of practice guidelines for the screening and diagnosis of lung cancer, and performed skill assessment and didactic teaching for physicians and health centres nationally and internationally. Over the years Dr. Flenaugh has been recognized for his accomplishments and, as a result, has received the 2010 Georgia Research Alliance’s Distinguished Clinician and Scholar Award.
Gabriela Oprea-Ilies, MD, is an Associate Professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. She provides pathology and cytology services at Grady Memorial Hospital. She earned her MD from the Institute of Medicine and Pharmacology in Romania. After obtaining her PhD, she completed residency programs at Emergency Hospital in Romania, Regions Medical Center in Minnesota, and the University of Minnesota. She also completed fellowships at the University of Minnesota and Emory University School of Medicine. She studies the inhomogenous nature of breast cancer, and as the principal investigator of the breast tissue bank, she is interested in questioning the molecular events of breast carcinogenesis in the context of its inhomogeneity as applied to a racially diverse, economically challenged population. She is also interested in HIV infection in women, and she studies the effect of HIV infection, from reactive to neoplastic, on different organs and systems, with an emphasis on women's health issues.
Rajesh Singh received his B.Sc., M.Sc., and Ph.D. from Banaras Hindu University. Currently, he is working as a Professor in Microbiology, Biochemistry, and Immunology at Morehouse School of Medicine. His research interests in cancer immunobiology, health disparity, drug discovery, precision oncology, nanotechnology, and chemokines, using in silico, in vitro, and in vivo models, contributing to multiple disciplines, including basic and translational oncology, vaccine development, and chemoprevention. His long-term goal is to improve cancer patients' therapeutic outcomes and overall survival and train the under-represented groups, thereby enhancing the diversity of the future biomedical workforce.
Shailesh Singh received his M.Sc. in Endocrinology and Reproductive Physiology and his Ph.D. in Cancer Biology from Banaras Hindu University. Currently, he is working as a Professor in Microbiology, Biochemistry, and Immunology at Morehouse School of Medicine. His long-term research interests include developing comprehensive treatment/prevention strategies for prostate, breast, and ovarian cancer. These strategies are directed to tumor cells and/or the immune system using natural and synthetic products as a single agent or in combination with conventional therapeutics.
